ClinicalTrials.Veeva

Menu

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

S

Simons Searchlight

Status

Enrolling

Conditions

ADNP
NLGN3
SHANK2
HNRNPU
PHF21A
NEXMIF
CTCF
CSNK2A1
1Q21.1 Deletion
NBEA
SCN2A Encephalopathy
IRF2BPL
CTNNB1 Gene Mutation
WAC
RIMS1
CHD3
ZNF292
NR4A2
NR3C2
TANC2
ANK2
15q11.2 BP1-BP2 Deletion
SETBP1 Gene Mutation
2q34 Duplication
DSCAM
KDM6B
ZBTB20
16p11.2 Triplications
NAA15
SMARCC2
NIPBL
GRIN2D
17Q12 Microdeletion Syndrome (Disorder)
VPS13B
EP300 Gene Mutation
16p11.2 Duplications
KMT5B
MED13
ARHGEF9
2p16.3 Deletions
SCN1B
SOX5
RERE
PSMD12
15q15 Deletions
DYNC1H1
6q16 Deletion
KDM5B
CHAMP1
9q34 Duplications
TCF7L2 Gene Mutation
SMARCA4 Gene Mutation
KATNAL2
GRIN2B
PHF3
16P13.11 Microdeletion Syndrome (Disorder)
EHMT1
ADSL
7q11.23 Duplications
MBD5
KCNB1
IQSEC2-Related Syndromic Intellectual Disability
1Q21.1 Microduplication Syndrome (Disorder)
TBR1
REST
WDFY3
PPP3CA
15Q13.3 Deletion Syndrome
DEAF1
KMT2A
SCN1A
CNOT3
DHCR7
AHDC1
SLC6A1
GRIN1
17Q12 Duplication Syndrome
YY1
ALDH5A1
ARID1B
CACNA1C
MAOA
FOXP1
EBF3
MBOAT7
ATRX Gene Mutation
RFX3
HNRNPC
DDX3X
NLGN2
PPP2R1A
NRXN1
CSDE1
2q37.3 Deletion
17Q21.31 Deletion Syndrome
STXBP1 Encephalopathy With Epilepsy
SPAST
CAPRIN1
PPP2R5D-Related Intellectual Disability
TAOK1
HNRNPR
TRIO
17q21.3 Duplications
GRIN2A
HECW2
EIF3F
5q35 Duplications
SON
HNRNPH2
PTCHD1
MED13L
BCL11A
ASH1L
2Q37 Deletion Syndrome
16P12.2 Microdeletion
USP9X
SRCAP
CASK
5P Deletion Syndrome
KANSL1
PACS1
BRSK2
HNRNPD
GIGYF1
PACS2
MEF2C
5q35 Deletions
SIN3A
ZNF462
PHIP
TCF20
KMT2C Gene Mutation
ANKRD11
15Q24 Deletion
SLC9A6
CTBP1
NLGN4X
CREBBP Gene Mutation
RELN
SETD5
CASZ1
17p13.3
CIC
17Q11.2 Microduplication Syndrome (Disorder)
BCKDK
ARX
NRXN2
DYRK1A
NSD1 Gene Mutation
HIVEP2-Related Intellectual Disability
ACTL6B
Xq28 Duplication
SYNGAP1-Related Intellectual Disability
HNRNPK
UPF3B
GNB1
SYNCRIP
CLCN4
RALGAPB
DLG4
CSNK2B
SETD2 Gene Mutation
TRIP12
NCKAP1
Xp11.22 Duplication
KDM3B
AUTS2 Syndrome
RORB
CHD8
CHD2
CUL3
MYT1L
MAOB
DNMT3A
TLK2
16P11.2 Deletion Syndrome
AFF2
16p13.3 Deletion
ACTB
POMGNT1
MEIS2
HNRNPUL2
KMT2E
ANK3

Study type

Observational

Funder types

Other

Identifiers

NCT01238250
Simons VIP Connect (Other Identifier)
2023-1257
Simons VIP (Other Identifier)
Simons Searchlight (Other Identifier)

Details and patient eligibility

About

Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment for these people. Simons Searchlight partners with families to collect data and distribute it to qualified researchers.

Full description

Simons Searchlight has expanded over the last several years to include additional gene changes and participation through remote formats, either online or by phone. This allows English and Spanish-speaking families from across the world to participate at times that are convenient to their schedule. Participants can donate blood, saliva, or both. These samples are then linked to medical, behavioral, learning, and developmental data in order to understand the effects of specific gene changes.

Information provided by participants will be stripped of any personal identifying information and made available to qualified scientists around the world.

The Simons Foundation, a New York-based private foundation, is committed to finding science-based solutions and working towards the development of targeted treatments to improve the lives of people who have genetic and developmental differences.

Enrollment

100,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects of any age with a genetic condition on our eligible list along with their biological family members. Current list can be found at: https://www.simonssearchlight.org/research/what-we-study/
  • Must be fluent in English or a supported language. Current supported languages are Spanish, French, and Dutch, with more to come.
  • Able to register and participate through our online platform, which can be accessed through any device able to connect to the internet.
  • Able and willing to provide consent.

Exclusion criteria

-Some genetic changes that we study have regions or variants that are not eligible for our research. This is determined during our laboratory review that is completed by trained and certified genetic counselors. These specific ineligible regions or variants can change frequently.

Trial design

100,000 participants in 2 patient groups

Copy Number Variants
Description:
Individuals with documented pathogenic or likely pathogenic copy number variants related to neurodevelopmental disorders.
Gene Variants
Description:
Individuals with documented pathogenic or likely pathogenic variants in a gene related to neurodevelopmental disorders.

Trial contacts and locations

2

Loading...

Central trial contact

Simons Searchlight Study Coordinator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems